GFH925

· Genfleet Therapeutics (Shanghai) Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for GFH925, covering 2025-08-12 to 2025-11-17. Get the full timeline:

Most recent: Clinical Trial Update: A Study of GFH925 in Patients With Advanced Solid Tumors With KRAS G12C Mutations [Phase 1, Phase 2]